Cubist Systematic Strategies’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-76,461
Closed -$415K 3557
2025
Q2
$415K Buy
76,461
+5,512
+8% +$27.5K ﹤0.01% 2322
2025
Q1
$246K Buy
+70,949
New +$344K ﹤0.01% 2450
2023
Q1
Sell
-10,489
Closed -$45.1K 4417
2022
Q4
$45.1K Sell
10,489
-72
-0.7% -$1.21K ﹤0.01% 3915
2022
Q3
$200K Buy
+10,561
New +$190K ﹤0.01% 3765

Other funds holding THRD

Cubist Systematic Strategies's THRD Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 76,461 shares — an estimated $415K sold.

Cubist Systematic Strategies first reported a position in THRD in Q3 2022 and held it in 4 quarters. The position peaked at $415K in Q2 2025. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 76,461 Third Harmonic Bio shares in Q3 2025, an estimated $415K.
  • Cubist Systematic Strategies first reported a position in Third Harmonic Bio in Q3 2022 and held it in 4 quarters.
  • Cubist Systematic Strategies's Third Harmonic Bio position peaked at $415K in Q2 2025.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.